Technology Detail

Home

Explore Technologies


The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.
Contact | 
Explore Technologies



A Novel Protein and Gene Expressed by Human T Cells and Monocytes: Alloreaction-Associated Antigen (ARAg)


Stanford Reference:

93-077


Abstract

Alloreaction-associated antigen (ARAg) is a novel member of the immunoglobulin superfamily. This invention's issued US patent claims composition of matter of ARAg polypeptides and nucleic acids encoding ARAg polypeptides.

Stanford research indicates ARAg may serve as an effector of immune response and a diagnostic antigen for antibody-based monitoring of immune disease.



Applications


  • Drug Target
  • Suppressing immune response using a monoclonal antibody against ARAg
  • Monitoring immune diseases using MAb as a diagnostic
  • Screening for ARAg receptors

U.S. Patent


U.S. Patent No. 5,646,251

Innovators & Portfolio



Patent Status



Date Released

 8/14/1997 12:00
 

Licensing Contact


Agreements Group
Request Info

79-066 Mouse Anti-Human Hybridomas: 12E7, L243, L17F12, L368
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes - RB6-8C5 and RA3-6B2
82-010 A Monoclonal Antibody Specific for the B-220 Surface Glycoprotein in Mouse (RA3-3A1)

more technologies »

Related Keywords


LS: molecular diagnostic: antibody   screening: target   LS: non-antibody protein/peptide therapeutic   screening   therapeutic